HEADER PROTEIN BINDING 25-MAY-22 7ZYL TITLE AVIDIN + BIOTIN-TEMPO COMPND MOL_ID: 1; COMPND 2 MOLECULE: AVIDIN; COMPND 3 CHAIN: A, B, C, D SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GALLUS GALLUS; SOURCE 3 ORGANISM_COMMON: CHICKEN; SOURCE 4 ORGANISM_TAXID: 9031 KEYWDS AVIDIN, BIOTIN, TEMPO FREE RADICAL, PROTEIN BINDING EXPDTA ELECTRON MICROSCOPY AUTHOR J.MILANI,A.MYASNIKOV,B.BECKERT,S.NAZAROV,J.P.ANSERMET,F.SAENZ REVDAT 1 14-JUN-23 7ZYL 0 JRNL AUTH J.MILANI,A.MYASNIKOV,B.BECKERT,S.NAZAROV,J.P.ANSERMET, JRNL AUTH 2 F.SAENZ JRNL TITL AVIDIN + BIOTIN-TEMPO JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.08 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : EPU, CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC REMARK 3 RECONSTRUCTION SCHEMA : FOURIER SPACE REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : FLEXIBLE FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.080 REMARK 3 NUMBER OF PARTICLES : 623000 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7ZYL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 25-MAY-22. REMARK 100 THE DEPOSITION ID IS D_1292122629. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : AVIDIN REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 4.00 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : FEI FALCON IV (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 900.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 1500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : 270000 REMARK 245 CALIBRATED MAGNIFICATION : 311110 REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11790 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 VAL A 2 REMARK 465 HIS A 3 REMARK 465 ALA A 4 REMARK 465 THR A 5 REMARK 465 SER A 6 REMARK 465 PRO A 7 REMARK 465 LEU A 8 REMARK 465 LEU A 9 REMARK 465 LEU A 10 REMARK 465 LEU A 11 REMARK 465 LEU A 12 REMARK 465 LEU A 13 REMARK 465 LEU A 14 REMARK 465 SER A 15 REMARK 465 LEU A 16 REMARK 465 ALA A 17 REMARK 465 LEU A 18 REMARK 465 VAL A 19 REMARK 465 ALA A 20 REMARK 465 PRO A 21 REMARK 465 GLY A 22 REMARK 465 LEU A 23 REMARK 465 SER A 24 REMARK 465 ALA A 25 REMARK 465 ARG A 26 REMARK 465 ARG A 148 REMARK 465 THR A 149 REMARK 465 GLN A 150 REMARK 465 LYS A 151 REMARK 465 GLU A 152 REMARK 465 MET B 1 REMARK 465 VAL B 2 REMARK 465 HIS B 3 REMARK 465 ALA B 4 REMARK 465 THR B 5 REMARK 465 SER B 6 REMARK 465 PRO B 7 REMARK 465 LEU B 8 REMARK 465 LEU B 9 REMARK 465 LEU B 10 REMARK 465 LEU B 11 REMARK 465 LEU B 12 REMARK 465 LEU B 13 REMARK 465 LEU B 14 REMARK 465 SER B 15 REMARK 465 LEU B 16 REMARK 465 ALA B 17 REMARK 465 LEU B 18 REMARK 465 VAL B 19 REMARK 465 ALA B 20 REMARK 465 PRO B 21 REMARK 465 GLY B 22 REMARK 465 LEU B 23 REMARK 465 SER B 24 REMARK 465 ALA B 25 REMARK 465 ARG B 26 REMARK 465 ARG B 148 REMARK 465 THR B 149 REMARK 465 GLN B 150 REMARK 465 LYS B 151 REMARK 465 GLU B 152 REMARK 465 MET C 1 REMARK 465 VAL C 2 REMARK 465 HIS C 3 REMARK 465 ALA C 4 REMARK 465 THR C 5 REMARK 465 SER C 6 REMARK 465 PRO C 7 REMARK 465 LEU C 8 REMARK 465 LEU C 9 REMARK 465 LEU C 10 REMARK 465 LEU C 11 REMARK 465 LEU C 12 REMARK 465 LEU C 13 REMARK 465 LEU C 14 REMARK 465 SER C 15 REMARK 465 LEU C 16 REMARK 465 ALA C 17 REMARK 465 LEU C 18 REMARK 465 VAL C 19 REMARK 465 ALA C 20 REMARK 465 PRO C 21 REMARK 465 GLY C 22 REMARK 465 LEU C 23 REMARK 465 SER C 24 REMARK 465 ALA C 25 REMARK 465 ARG C 26 REMARK 465 ARG C 148 REMARK 465 THR C 149 REMARK 465 GLN C 150 REMARK 465 LYS C 151 REMARK 465 GLU C 152 REMARK 465 MET D 1 REMARK 465 VAL D 2 REMARK 465 HIS D 3 REMARK 465 ALA D 4 REMARK 465 THR D 5 REMARK 465 SER D 6 REMARK 465 PRO D 7 REMARK 465 LEU D 8 REMARK 465 LEU D 9 REMARK 465 LEU D 10 REMARK 465 LEU D 11 REMARK 465 LEU D 12 REMARK 465 LEU D 13 REMARK 465 LEU D 14 REMARK 465 SER D 15 REMARK 465 LEU D 16 REMARK 465 ALA D 17 REMARK 465 LEU D 18 REMARK 465 VAL D 19 REMARK 465 ALA D 20 REMARK 465 PRO D 21 REMARK 465 GLY D 22 REMARK 465 LEU D 23 REMARK 465 SER D 24 REMARK 465 ALA D 25 REMARK 465 ARG D 26 REMARK 465 ARG D 148 REMARK 465 THR D 149 REMARK 465 GLN D 150 REMARK 465 LYS D 151 REMARK 465 GLU D 152 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 27 CB CG CD CE NZ REMARK 470 LYS B 27 CB CG CD CE NZ REMARK 470 LYS C 27 CB CG CD CE NZ REMARK 470 LYS D 27 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU C 98 ND2 ASN D 81 2.10 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 81 -4.57 74.58 REMARK 500 ASP A 110 -175.37 -69.32 REMARK 500 ASP C 110 -175.59 -69.11 REMARK 500 ASP D 110 -175.62 -69.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-15026 RELATED DB: EMDB REMARK 900 AVIDIN + BIOTIN-TEMPO DBREF 7ZYL A 1 152 UNP P02701 AVID_CHICK 1 152 DBREF 7ZYL B 1 152 UNP P02701 AVID_CHICK 1 152 DBREF 7ZYL C 1 152 UNP P02701 AVID_CHICK 1 152 DBREF 7ZYL D 1 152 UNP P02701 AVID_CHICK 1 152 SEQRES 1 A 152 MET VAL HIS ALA THR SER PRO LEU LEU LEU LEU LEU LEU SEQRES 2 A 152 LEU SER LEU ALA LEU VAL ALA PRO GLY LEU SER ALA ARG SEQRES 3 A 152 LYS CYS SER LEU THR GLY LYS TRP THR ASN ASP LEU GLY SEQRES 4 A 152 SER ASN MET THR ILE GLY ALA VAL ASN SER ARG GLY GLU SEQRES 5 A 152 PHE THR GLY THR TYR ILE THR ALA VAL THR ALA THR SER SEQRES 6 A 152 ASN GLU ILE LYS GLU SER PRO LEU HIS GLY THR GLN ASN SEQRES 7 A 152 THR ILE ASN LYS ARG THR GLN PRO THR PHE GLY PHE THR SEQRES 8 A 152 VAL ASN TRP LYS PHE SER GLU SER THR THR VAL PHE THR SEQRES 9 A 152 GLY GLN CYS PHE ILE ASP ARG ASN GLY LYS GLU VAL LEU SEQRES 10 A 152 LYS THR MET TRP LEU LEU ARG SER SER VAL ASN ASP ILE SEQRES 11 A 152 GLY ASP ASP TRP LYS ALA THR ARG VAL GLY ILE ASN ILE SEQRES 12 A 152 PHE THR ARG LEU ARG THR GLN LYS GLU SEQRES 1 B 152 MET VAL HIS ALA THR SER PRO LEU LEU LEU LEU LEU LEU SEQRES 2 B 152 LEU SER LEU ALA LEU VAL ALA PRO GLY LEU SER ALA ARG SEQRES 3 B 152 LYS CYS SER LEU THR GLY LYS TRP THR ASN ASP LEU GLY SEQRES 4 B 152 SER ASN MET THR ILE GLY ALA VAL ASN SER ARG GLY GLU SEQRES 5 B 152 PHE THR GLY THR TYR ILE THR ALA VAL THR ALA THR SER SEQRES 6 B 152 ASN GLU ILE LYS GLU SER PRO LEU HIS GLY THR GLN ASN SEQRES 7 B 152 THR ILE ASN LYS ARG THR GLN PRO THR PHE GLY PHE THR SEQRES 8 B 152 VAL ASN TRP LYS PHE SER GLU SER THR THR VAL PHE THR SEQRES 9 B 152 GLY GLN CYS PHE ILE ASP ARG ASN GLY LYS GLU VAL LEU SEQRES 10 B 152 LYS THR MET TRP LEU LEU ARG SER SER VAL ASN ASP ILE SEQRES 11 B 152 GLY ASP ASP TRP LYS ALA THR ARG VAL GLY ILE ASN ILE SEQRES 12 B 152 PHE THR ARG LEU ARG THR GLN LYS GLU SEQRES 1 C 152 MET VAL HIS ALA THR SER PRO LEU LEU LEU LEU LEU LEU SEQRES 2 C 152 LEU SER LEU ALA LEU VAL ALA PRO GLY LEU SER ALA ARG SEQRES 3 C 152 LYS CYS SER LEU THR GLY LYS TRP THR ASN ASP LEU GLY SEQRES 4 C 152 SER ASN MET THR ILE GLY ALA VAL ASN SER ARG GLY GLU SEQRES 5 C 152 PHE THR GLY THR TYR ILE THR ALA VAL THR ALA THR SER SEQRES 6 C 152 ASN GLU ILE LYS GLU SER PRO LEU HIS GLY THR GLN ASN SEQRES 7 C 152 THR ILE ASN LYS ARG THR GLN PRO THR PHE GLY PHE THR SEQRES 8 C 152 VAL ASN TRP LYS PHE SER GLU SER THR THR VAL PHE THR SEQRES 9 C 152 GLY GLN CYS PHE ILE ASP ARG ASN GLY LYS GLU VAL LEU SEQRES 10 C 152 LYS THR MET TRP LEU LEU ARG SER SER VAL ASN ASP ILE SEQRES 11 C 152 GLY ASP ASP TRP LYS ALA THR ARG VAL GLY ILE ASN ILE SEQRES 12 C 152 PHE THR ARG LEU ARG THR GLN LYS GLU SEQRES 1 D 152 MET VAL HIS ALA THR SER PRO LEU LEU LEU LEU LEU LEU SEQRES 2 D 152 LEU SER LEU ALA LEU VAL ALA PRO GLY LEU SER ALA ARG SEQRES 3 D 152 LYS CYS SER LEU THR GLY LYS TRP THR ASN ASP LEU GLY SEQRES 4 D 152 SER ASN MET THR ILE GLY ALA VAL ASN SER ARG GLY GLU SEQRES 5 D 152 PHE THR GLY THR TYR ILE THR ALA VAL THR ALA THR SER SEQRES 6 D 152 ASN GLU ILE LYS GLU SER PRO LEU HIS GLY THR GLN ASN SEQRES 7 D 152 THR ILE ASN LYS ARG THR GLN PRO THR PHE GLY PHE THR SEQRES 8 D 152 VAL ASN TRP LYS PHE SER GLU SER THR THR VAL PHE THR SEQRES 9 D 152 GLY GLN CYS PHE ILE ASP ARG ASN GLY LYS GLU VAL LEU SEQRES 10 D 152 LYS THR MET TRP LEU LEU ARG SER SER VAL ASN ASP ILE SEQRES 11 D 152 GLY ASP ASP TRP LYS ALA THR ARG VAL GLY ILE ASN ILE SEQRES 12 D 152 PHE THR ARG LEU ARG THR GLN LYS GLU HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET NAG G 1 14 HET NAG G 2 14 HET NAG H 1 14 HET NAG H 2 14 HET KFL A 201 63 HET KFL B 201 63 HET KFL C 201 63 HET KFL D 201 63 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM KFL 6-[(3~{A}~{S},4~{S},6~{A}~{R})-2-OXIDANYLIDENE-1,3, HETNAM 2 KFL 3~{A},4,6,6~{A}-HEXAHYDROTHIENO[3,4-D]IMIDAZOL-4-YL]- HETNAM 3 KFL ~{N}-(2,2,6,6-TETRAMETHYL-1-OXIDANYL-PIPERIDIN-4-YL) HETNAM 4 KFL HEXANAMIDE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 NAG 8(C8 H15 N O6) FORMUL 9 KFL 4(C20 H36 N4 O3 S) HELIX 1 AA1 THR A 79 ARG A 83 5 5 HELIX 2 AA2 ASP A 129 LYS A 135 5 7 HELIX 3 AA3 THR B 79 ARG B 83 5 5 HELIX 4 AA4 ASP B 129 LYS B 135 5 7 HELIX 5 AA5 THR C 79 ARG C 83 5 5 HELIX 6 AA6 ASP C 129 LYS C 135 5 7 HELIX 7 AA7 ASP D 129 LYS D 135 5 7 SHEET 1 AA1 9 GLY A 32 ASN A 36 0 SHEET 2 AA1 9 ASN A 41 ILE A 44 -1 O MET A 42 N TRP A 34 SHEET 3 AA1 9 GLU A 52 ILE A 58 -1 O ILE A 58 N ASN A 41 SHEET 4 AA1 9 SER A 71 GLN A 77 -1 O SER A 71 N TYR A 57 SHEET 5 AA1 9 THR A 87 ASN A 93 -1 O THR A 91 N HIS A 74 SHEET 6 AA1 9 THR A 100 ILE A 109 -1 O THR A 101 N VAL A 92 SHEET 7 AA1 9 GLU A 115 ARG A 124 -1 O ARG A 124 N THR A 100 SHEET 8 AA1 9 THR A 137 ARG A 146 -1 O GLY A 140 N TRP A 121 SHEET 9 AA1 9 GLY A 32 ASN A 36 -1 N THR A 35 O THR A 145 SHEET 1 AA2 9 GLY B 32 ASN B 36 0 SHEET 2 AA2 9 ASN B 41 ILE B 44 -1 O MET B 42 N TRP B 34 SHEET 3 AA2 9 GLU B 52 ILE B 58 -1 O ILE B 58 N ASN B 41 SHEET 4 AA2 9 SER B 71 GLN B 77 -1 O SER B 71 N TYR B 57 SHEET 5 AA2 9 THR B 87 ASN B 93 -1 O THR B 91 N HIS B 74 SHEET 6 AA2 9 THR B 100 ILE B 109 -1 O THR B 101 N VAL B 92 SHEET 7 AA2 9 GLU B 115 ARG B 124 -1 O ARG B 124 N THR B 100 SHEET 8 AA2 9 THR B 137 ARG B 146 -1 O GLY B 140 N TRP B 121 SHEET 9 AA2 9 GLY B 32 ASN B 36 -1 N THR B 35 O THR B 145 SHEET 1 AA3 9 GLY C 32 ASN C 36 0 SHEET 2 AA3 9 ASN C 41 ILE C 44 -1 O MET C 42 N TRP C 34 SHEET 3 AA3 9 GLU C 52 ILE C 58 -1 O ILE C 58 N ASN C 41 SHEET 4 AA3 9 SER C 71 GLN C 77 -1 O SER C 71 N TYR C 57 SHEET 5 AA3 9 THR C 87 ASN C 93 -1 O THR C 91 N HIS C 74 SHEET 6 AA3 9 THR C 100 ILE C 109 -1 O THR C 101 N VAL C 92 SHEET 7 AA3 9 GLU C 115 ARG C 124 -1 O ARG C 124 N THR C 100 SHEET 8 AA3 9 THR C 137 ARG C 146 -1 O GLY C 140 N TRP C 121 SHEET 9 AA3 9 GLY C 32 ASN C 36 -1 N THR C 35 O THR C 145 SHEET 1 AA4 9 GLY D 32 ASN D 36 0 SHEET 2 AA4 9 ASN D 41 ILE D 44 -1 O MET D 42 N TRP D 34 SHEET 3 AA4 9 GLU D 52 ILE D 58 -1 O ILE D 58 N ASN D 41 SHEET 4 AA4 9 SER D 71 GLN D 77 -1 O SER D 71 N TYR D 57 SHEET 5 AA4 9 THR D 87 ASN D 93 -1 O THR D 91 N HIS D 74 SHEET 6 AA4 9 THR D 100 ILE D 109 -1 O THR D 101 N VAL D 92 SHEET 7 AA4 9 GLU D 115 ARG D 124 -1 O ARG D 124 N THR D 100 SHEET 8 AA4 9 THR D 137 ARG D 146 -1 O GLY D 140 N TRP D 121 SHEET 9 AA4 9 GLY D 32 ASN D 36 -1 N THR D 35 O THR D 145 SSBOND 1 CYS A 28 CYS A 107 1555 1555 2.03 SSBOND 2 CYS B 28 CYS B 107 1555 1555 2.03 SSBOND 3 CYS C 28 CYS C 107 1555 1555 2.03 SSBOND 4 CYS D 28 CYS D 107 1555 1555 2.03 LINK ND2 ASN A 41 C1 NAG E 1 1555 1555 1.45 LINK ND2 ASN B 41 C1 NAG F 1 1555 1555 1.45 LINK ND2 ASN C 41 C1 NAG G 1 1555 1555 1.45 LINK ND2 ASN D 41 C1 NAG H 1 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.44 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.44 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.44 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000